XML 39 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
STATEMENTS OF CONSOLIDATED CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Cumulative Preferred Stock
Cumulative Preferred Stock
Series C Preferred Stock
Cumulative Preferred Stock
Series B and Series C Preferred Stock
Common Stock
Additional Paid-in-Capital
Additional Paid-in-Capital
Series B and Series C Preferred Stock
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Series A Preferred Stock
Retained Earnings (Accumulated Deficit)
Series B Preferred Stock
Retained Earnings (Accumulated Deficit)
Series C Preferred Stock
Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Dec. 31, 2018         2,000,000                      
Balance, beginning of year at Dec. 31, 2018         $ 1,740     $ 5 $ 6,072   $ 349 $ 0       $ (108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issued (in shares)           0   0                
Stock issued           $ 0   $ 0 0              
Conversion of Series B Preferred Stock and Series C Preferred Stock (in shares)             0                  
Conversion of Series B Preferred Stock and Series C Preferred Stock             $ 0     $ 0            
Balance, end of year (in shares) at Dec. 31, 2019 1,777,500 800,000 977,500 0 2,000,000                      
Balance, beginning of year (in shares) at Dec. 31, 2018               501,000,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance related to benefit and investment plans (in shares)               1,000,000                
Issuances related to benefit and investment plans               $ 0 8              
Recognition of beneficial conversion feature $ 0               0              
Net income (loss) 791                   791          
Common Stock dividends declared (see Note 13)                     (433)          
Preferred stock dividends declared                         $ (24) $ (51) $ 0  
Amortization of beneficial conversion feature $ 0                   0          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]                              
Other comprehensive income                               10
Balance, end of year (in shares) at Dec. 31, 2019               502,000,000                
Balance, end of year at Dec. 31, 2019 $ 8,359       $ 1,740     $ 5 6,080   632 (7)       (98)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issued (in shares)           1,000,000   48,000,000                
Stock issued           $ 723   $ 1 672              
Conversion of Series B Preferred Stock and Series C Preferred Stock (in shares)             0                  
Conversion of Series B Preferred Stock and Series C Preferred Stock             $ (100)     100            
Balance, end of year (in shares) at Dec. 31, 2020 2,402,400 800,000 977,400 625,000 3,000,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance related to benefit and investment plans (in shares)               1,000,000                
Issuances related to benefit and investment plans               $ 0 30              
Recognition of beneficial conversion feature $ 32               32              
Net income (loss) (773)                   (773)          
Common Stock dividends declared (see Note 13)                     (480)          
Preferred stock dividends declared                         (73) (85) (27)  
Amortization of beneficial conversion feature $ (32)                   (32)          
Other comprehensive income                               8
Balance, end of year (in shares) at Dec. 31, 2020 551,355,861             551,000,000                
Balance, end of year at Dec. 31, 2020 $ 8,348       $ 2,363     $ 6 6,914   (845) $ 0       (90)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issued (in shares)           0   77,000,000                
Stock issued           $ 0   $ 0 1              
Conversion of Series B Preferred Stock and Series C Preferred Stock (in shares)             (2,000,000)                  
Conversion of Series B Preferred Stock and Series C Preferred Stock             $ (1,573)     $ 1,573            
Balance, end of year (in shares) at Dec. 31, 2021 800,000 800,000 0 0 1,000,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance related to benefit and investment plans (in shares)               1,000,000                
Issuances related to benefit and investment plans               $ 0 41              
Recognition of beneficial conversion feature $ 0               0              
Net income (loss) 1,486                   1,486          
Common Stock dividends declared (see Note 13)                     (404)          
Preferred stock dividends declared                         $ (49) $ (34) $ 0  
Amortization of beneficial conversion feature $ 0                   0          
Other comprehensive income                               26
Balance, end of year (in shares) at Dec. 31, 2021 628,923,534             629,000,000                
Balance, end of year at Dec. 31, 2021 $ 9,415       $ 790     $ 6 $ 8,529   $ 154         $ (64)